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ApoptosisRenal ischemia–reperfusion leads to acute kidney injury (AKI) that is characterized pathologically by tubular
damage and cell death, followed by tubular repair, atrophy and interstitial ﬁbrosis. Recent work suggested the
possible presence of DNA damage response (DDR) in AKI. However, the evidence is sketchy and the role and reg-
ulation of DDR in ischemic AKI remain elusive. In this study, we demonstrated the induction of phosphorylation
of ATM, H2AX, Chk2 and p53 during renal ischemia–reperfusion in mice, suggesting DDR in kidney tissues. DDR
was also induced in vitro during the recovery or “reperfusion” of renal proximal tubular cells (RPTCs) after ATP
depletion. DDR in RPTCs was abrogated by supplying glucose to maintain ATP via glycolysis, indicating that the
DDR depends on ATP depletion. The DDR was also suppressed by the general caspase inhibitor z-VAD and the
overexpression of Bcl-2, supporting a role of apoptosis-associated DNA damage in the DDR. N-acetylcysteine
(NAC), an antioxidant, suppressed the phosphorylation of ATM and p53 and, to a less extent, Chk2, but NAC in-
creased the phosphorylation and nuclear foci formation of H2AX. Interestingly, NAC increased apoptosis, which
may account for the observed H2AX activation. Ku55933, an ATM inhibitor, blocked ATM phosphorylation and
ameliorated the phosphorylation of Chk2 and p53, but it increased H2AX phosphorylation and nuclear foci for-
mation. Ku55933 also increased apoptosis in RPTCs following ATP depletion. The results suggest that DDR occurs
during renal ischemia–reperfusion in vivo and ATP-depletion injury in vitro. The DDR is partially induced by ap-
optosis and oxidative stress-related DNA damage. ATM, as a sensor in the DDR, may play a cytoprotective role
against tubular cell injury and death.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Renal ischemia–reperfusion is a major cause of acute kidney injury
(AKI), which leads to high mortality in patients and may progress to
chronic kidney disease. Pathologically, ischemic AKI is characterized
by sublethal and lethal damages in renal tubules, especially the proxi-
mal tubules [1,2]. Cell death in renal tubules in the forms of both apo-
ptosis and necrosis is detected in animal models as well as the kidneys
of AKI patients. Interestingly, renal tubules possess the capacity of repair
and when the repair is incomplete, ﬁbrosis or “scar” develops, contrib-
uting to gradual loss of renal function and chronic deﬁciency [3,4]. The
molecular basis of tubular cell death and repair remains poorly
understood.
DNA damage occurs in a variety of conditions such as irradiation, UV
exposure, genotoxic chemical challenge, and oxidative stress or free, The Second Xiangya Hospital,
1 706 721 2825.radical insult. In response to DNA damage, cells activate a network of
signaling pathways known as DNA damage response (DDR). DDR starts
from the activation of the ‘sensor’ protein kinases, including the
phosphoinositol 3-kinase-like serine/threonine protein kinases ataxia
telangiectasis mutated (ATM), ATM- and Rad3-related (ATR), and
DNA-dependent protein kinase (DNA-PK). The ‘sensor’ kinases relay
the signal to the ‘executors’ kinases, especially Check-point kinases
(Chk1 and Chk2), which then phosphorylate a multitude of proteins
to induce cell cycle arrest or, in the presence of severe DNA damage,
cell death [5–7].
DNA damage, such as the accumulation of 8-oxo-dG and apoptosis-
associated DNA cleavage in renal tubular cells, is known to occur in kid-
ney tissues following ischemia–reperfusion [8–10]. In experimental
models of renal ischemia–reperfusion, p53 is activated and inhibition
of p53 provides renoprotective effects, implying the possibility of DDR
[11,12]. However, DDR has not been studied in kidney cells or tissues
during renal ischemia–reperfusion. In cisplatin-induced AKI, we have
delineated a DDR signaling pathway that involves the activation of
ATR followed by Chk2 activation and the phosphorylation of p53,
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in tubular cell death [13–15].Whether DDR occurs in renal ischemia–re-
perfusion and what role it plays in kidney injury and repair remain
largely unknown.
In the present study, we detected DDR in kidney tissues during is-
chemia–reperfusion in mice and in ATP-depleted renal tubular cells.
The DDR was suppressed to various extents by the ATM inhibitor
Ku55933, the antioxidant N-acetylcysteine, the general caspase inhibi-
tor z-VAD and overexpression of Bcl-2. It is suggested that DDR occurs
in ischemic AKI viamultiplemechanisms, including apoptotic DNA frag-
mentation and oxidative stress.2. Materials and methods
2.1. Reagents and antibodies
Antibodies were from the following sources: anti-Chk1 from
Epitomics (Burlingame, CA); anti-Chk2, Anti-p53, anti-γH2AX, anti-
PARP and anti-phosphorylated Chk1(serine 345) from Cell Signaling
Technology (Beverly, MA), anti-phosphorylated Chk2(Thronine-68)
fromNovus (Littleton, CO), anti-ATM antibody fromAbcam (Cambridge,
MA), anti-phosphorylated ATM(serine-1981) from Millipore (Billerica,
MA); anti-β-actin from Sigma (St. Louis, MO); all secondary antibodies
from Jackson ImmunoResearch (West Grove, PA). Ku55933 was
purchased from Selleck (Houston, TX). Other reagents and chemicals in-
cluding azide were purchased from Sigma (St. Louis, MO).2.2. Renal ischemia–reperfusion
Male mice of 8 to 10 week old C57BL/6 mice were purchased from
Jackson Laboratory (Bar Harbor, MN) and maintained in the animal
facility of Charlie Norwood VA Medical Center under a 12-hour light/
12-hour dark pattern with free access to food and water. All animal ex-
periments were performed according to a protocol approved by the In-
stitutional Animal Care and Use Committee of Charlie Norwood VA
Medical Center. Renal ischemia–reperfusionwas induced as detailed re-
cently [16]. Brieﬂy, after anesthetization with pentobarbital (50 mg/kg,
i.p.), the mice were kept on a Homoeothermic Blanket Control Unit
(Harvard Apparatus Ltd, UK) with a rectal probe to monitor and main-
tain the body temperature at 36.4 °C. Flank incisions were made to ex-
pose both renal pedicles for bilateral clamping to induce 30 min of
renal ischemia. The clamps were then released for reperfusion. Kidneys
were collected after 48 h of reperfusion for the following examinations.
Color changes of kidneys during the initiation of clamping and after re-
moval of clamps were observed to monitor the renal ischemia and re-
perfusion. Control animals were subjected to sham operation without
renal pedicle clamping. Renal function was monitored by measuring
BUNand serumcreatinine using analytical kits fromBiotronDiagnostics
(Hemet, CA) and Stanbio Laboratory (Boerne, TX), respectively.2.3. Immunohistochemistry
Kidneys were collected and ﬁxed in 4% paraformaldehyde, parafﬁn
embedded, and sectioned at 4 μm. The tissue sections were then
deparafﬁnized and rehydrated, Antigen retrieval was conducted by 1 h
of incubation at 95 °C in 0.01 M sodium citrate, pH 6.0. The tissues
were subsequently incubated with 3% H2O2 at 37 °C for 30 min to
block the endogenous peroxidase activity. Then, the tissues were incu-
bated sequentially with a blocking buffer (2% BSA, 0.2% nonfat dry
milk, 0.8% Triton X-100, and 2% normal donkey serum) and the anti-
γH2AX antibody (1:250 dilution, Cell Signaling, Danvers, USA) in the
blocking buffer. After incubation with biotin-labeled secondary anti-
body, the color was developedwith an ABC kit fromVector Laboratories
(Burlingame, CA). The staining was evaluated in a blinded manner.2.4. Cell ATP depletion and recovery
The rat kidney proximal tubular cell line (RPTC) was originally ob-
tained from Dr. U. Hopfer (Case Western Reserve Univ., Cleveland,
OH) and cultured in serum-supplemented Ham's F-12/Dulbecco's mod-
iﬁed Eagle'smediumwith 17.5 mM glucose as described previously [17,
18]. Stable Bcl-2-overexpressing RPTC were generated as described be-
fore [18]. For the experiment, the cells were seeded in 35 mm collagen-
coated dishes. After overnight growth, the cells were washed with
phosphate-buffered saline and subjected to ATPdepletion by incubation
in glucose-free Krebs–Ringer bicarbonate buffer containing 10 mM
azide. Following ATP depletion, the cells were incubated in full culture
medium without azide for recovery or ‘reperfusion’.
2.5. Apoptosis evaluation
Cells were ﬁxed with 4% paraformaldehyde and the nuclei were
stained byHoechst 33342. The apoptotic cells were identiﬁed by the ap-
optotic morphology under phase contrast microscope and the con-
densed nuclei under ﬂuorescent microscope.
2.6. Immunoblot analysis
A standard protocol of immunoblot analysis was followed. Brieﬂy,
the protein concentration of cell lysate was determined by using the
BCA reagent (Pierce, Rockford, IL). Equal amounts of proteins (20 μg)
were loaded for reducing SDS-gel electrophoresis, followed by transfer-
ring onto polyvinylidene diﬂuoridemembranes. The blots were then in-
cubated sequentially in blocking buffer, primary antibody, and the
horseradish peroxidase-conjugated secondary antibody. Finally, the an-
tigens on the blots were revealed using the enhanced chemilumines-
cence kit from Pierce. All primary antibodies were used at 1:1000
dilutions for immunoblot analysis.
2.7. Immunoﬂuorescence
Cells were grown on glass coverslips for indirect immunoﬂuores-
cence as described previously [13]. Brieﬂy, the cells were ﬁxed with
4% paraformaldehyde and permeabilized with 0.4% Triton X-100 in a
blocking buffer. The cells were then exposed to primary antibodies,
followed by incubation with Cy3-labeled donkey anti-rabbit secondary
antibodies. The nuclei were counter-stained by Hoechst 33342. After
washes, the coverslips were mounted on slides with Antifade (Life
Technologies, Grand Island, NY) for examination by confocal microsco-
py using Cy3 and DAPI channels.
2.8. MTT assay
After azide treatment, the cellswere recovered for 24 h in full culture
medium to determine cell viability usingMTT assay kit according to the
manufacturer's instruction (Molecular Probes, Eugene, OR).
2.9. Statistics
All data were analyzed by Microsoft Excel 2010 or SPSS. Student t-
test or One-way ANOVA analysis was used for statistics and P b 0.05
was considered as signiﬁcantly different.
3. Results
3.1. DDR is induced in kidney tissues during renal ischemia–reperfusion
We used a commonly used mouse model of renal ischemia–
reperfusion to examine DDR in the kidney tissues. As shown in Fig. 1A,
30 min of bilateral renal ischemia followed by 48 h of reperfusion in-
duced the loss of renal function as indicated by signiﬁcant increases in
Fig. 1.DDR is induced in kidney tissues during ischemia–reperfusion inmice. C57BL/6malemicewere subjected to shamoperation or 30min of bilateral renal ischemia, followedby48h of
reperfusion. (A) Blood sampleswere collected for themeasurement of blood urea nitrogen and serum creatinine. Data are presented asmean±SD (n=7); *, p b 0.05 vs. shamcontrol. (B)
Kidney cortex and outer medulla tissue were collected for immunoblot analysis of phosphorylated (Serine 1981) ATM, total ATM, phosphorylated (threonine 68) Chk2, total Chk2, phos-
phorylated (Serine 15) p53, total p53, phosphorylated H2AX (γH2AX), and cyclophilin B as the protein loading control. (C) Quantitative analysis of the ratio of phosphorylated (Serine
1981) ATM, total ATM, phosphorylated (threonine 68) Chk2, total Chk2, phosphorylated (Serine 15) p53, total p53, phosphorylated H2AX (γH2AX) to Cyclophilin B. Data are mean ±
SD (n = 3). (D) Representative images of immunohischemistry staining of γH2AX in kidney cortex, It demonstrates that γH2AX is expressed in the nuclei. (E) Quantitative analysis of
γH2AX-positive tubular epithelial cells in Fig.(1D). γH2AX-positive cells were quantiﬁed by cell counting in comparable regions of the tissues. Data are shown as means ± SD (n = 5).
*, P b 0.05 vs. Sham control.
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DDR, we ﬁrst examined the expression of ATM, a DNA damage sensor
that is rapidly recruited to the double strand breaks by the Mre11–
Rad50–Nbs1 complex to phosphorylate the downstream ‘effector’ pro-
tein kinases including Chk2 [19–21]. As shown in Fig. 1B and C, ATM
expression was barely detectable in control tissues, but it was induced
dramatically in mouse kidney tissues after ischemia–reperfusion. ATM
phosphorylation at Ser1981 was also moderately induced by renal
ischemia–reperfusion. Correlatively, Chk2 phosphorylation was in-
creased, whichwas accompaniedwith increases in both total and phos-
phorylated p53 (ser-15) (Fig. 1B). In mammalian cells, histone H2AX
phosphorylation at ser139 by ATM is a biochemical hallmark of DDR.
PhosphorylatedH2AX, also calledγH2AX, accumulates at the DNAdam-
age site to recruit DNA repair complex to form nuclei foci [22,23].
γH2AX was low in sham operated kidneys and was induced following
ischemia–reperfusion. γH2AX positive tubular epithelial cells were sig-
niﬁcantly increased in ischemia–reperfusion cortex tissues compared to
the sham control (Fig. 1D, E), further implying the induction of DDR fol-
lowing ischemia–reperfusion. Together, these results indicate the in-
duction of DDR during renal ischemia–reperfusion.
3.2. DDR is induced in RPTCs following azide-induced ATP depletion injury
To study the mechanism of DDR in renal ischemia–reperfusion, we
used an in vitro model of ‘chemical hypoxia’, in which RPTCs wereincubated with azide (an inhibitor of respiratory complex IV) in a
glucose-free buffer to induced ATP depletion. After ATP depletion, the
cells were returned to full culture medium for recovery to mimic reper-
fusion. This in vitro model was used to investigate cell injury in renal
ischemia–reperfusion in our recent studies [17,24,25]. γH2AX was not
detected in control cells and was not induced during ATP depletion
(Fig. 2A: lanes 1, 2). However, after ATP-depleted cells were returned
to full culturemedium for recovery or ‘reperfusion’,γH2AXwas induced
at 1 h, reached a higher level at 3 h and remained to be elevated after 20
h (Fig. 2A: lanes 3–5). Immunoﬂuorescence showed weak, diffuse sig-
nals ofγH2AX in the nuclei of most control cells. However, after ATP de-
pletion and recovery, γH2AX accumulated to form nuclear foci (Fig. 2B).
Interestingly, a signiﬁcant population of the γH2AX positive nuclei was
not apoptotic as indicated by double staining with DAPI (Fig. 2C). The
phosphorylation of ATM, Chk2 and p53 was increased during recovery
of ATP-depleted cells (Fig. 2 D, E: lanes 3, 4), further conﬁrming the in-
duction of DDR in this in vitro model.
3.3. Glucose added during azide treatment prevents DDR
What triggers DDR during the recovery of ATP-depleted RPTCs?
With this question, we ﬁrst determined if the DDR is related to ATP de-
pletion. Previous work demonstrated that glucose provided during mi-
tochondrial inhibition enables cellular ATP production via glycolysis
[18]. Thus we examined the effect of glucose added during azide
vFig. 2.DDR is induced following ATP-depletion injury in RPTC. RPTC cells were left untreated (control) or treatedwith 10mMsodium azide for 3 h, followed by recovery in fullmedium for
0, 1, 2, 3 or 20 h as indicated. (A)Whole cell lysate was collected for immunoblot analysis of phosphorylated H2AX (γH2AX), and β-actin (sample loading control); (B, C) The cells were
ﬁxed and subjected to immunoﬂuorescence staining of phosphorylated H2AX (γH2AX). (D) Whole cell lysate was collected for immunoblot analysis of phosphorylated (Serine 1981)
ATM, total ATM and β-actin. (E) Whole cell lysate was collected for immunoblot analysis of phosphorylated (threonine 68) Chk2, total Chk2, phosphorylated (Ser15) p53, total p53,
and β-actin.
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ing azide treatment attenuated the induction of γH2AX and the phos-
phorylation of ATM at 1 and 3 h of recovery(lanes 4, 5 vs. 3, lanes 7, 8
vs. 6), indicating that DDR in this model is causally related to the initial
ATP depletion.
3.4. Inhibition of DDR following azide treatment by Z-VAD and Bcl-2
We showed previously that renal ischemia–reperfusion and ATP de-
pletion in RPTCs activate the mitochondrial pathway of apoptosis [17,
24,26]. Since apoptosis is associated with extensive internucleosomal
DNA cleavage, we reasoned that the DDR observed during the recovery
period of ATP-depleted cells may be partly attributable to apoptosis. To
test this possibility, the pan-caspase inhibitor Z-VAD was added duringFig. 3.Glucose added during azide treatment prevents DDR. RPTC cells were left untreated
(control) or treated with 10 mM sodium azide for 3 h in the presence or absence of 5 or
10 mM D-Glucose, followed by recovery in full medium for 0, 1, or 3 h. Whole cell lysate
was collected for immunoblot analysis of phosphorylated (Serine 1981) ATM and phos-
phorylated H2AX (γH2AX). β-actin was used as a loading control.ATP depletion and the subsequent recovery to suppress apoptosis. As
expected, 50 and 100 μM Z-VAD blocked the cleavage of caspase 3 and
PARP, a biochemical hallmark of apoptosis, during azide treatment
and 3 h of recovery (Fig. 4A: lanes 4, 5 vs. 3). Notably, Z-VAD also atten-
uated γH2AX expression, while the phosphorylation of ATM, Chk2, and
p53 was only marginally inhibited by Z-VAD (Fig. 4A: lanes 4, 5 vs. 3).
We further examined the effect of overexpression of Bcl-2, a well-
known anti-apoptotic gene. As shown in Fig. 4B (lanes 7, 8 vs. 3, 4),
Bcl-2 overexpression totally blocked γH2AX induction and signiﬁcantly
blocked ATM, Chk2 and p53 phosphorylation. As shown previously [17,
26], azide-induced apoptosis was markedly suppressed in Bcl-2-
overexpressing cells (Fig. 4C). Together, these results suggest that
apoptosis-associated DNA cleavage contributes signiﬁcantly to the
DDR observed in this ATP-depletion/recovery model.3.5. N-acetylcysteine suppresses ATM activation during recovery of
ATP-depleted cells
Mitochondria are an important source for reactive oxygen species
(ROS) generation inside the cells [27]. The generation of ROS in the
form of superoxide anion is only 3 to 5% of total oxygen consumed dur-
ing normal oxidative phosphorylation [28]. However, under conditions
when oxidative phosphorylation is inhibited, this rate of ROS produc-
tion can be increased greatly [29,30]. Oxidative stress resulting from
ROS is a known pathogenic factor in renal ischemia/reperfusion injury
[31]. ROS inﬂict damage on lipids, proteins and DNAs [32–35]. In order
to clarify the role of ROS in the DDR observed during recovery of ATP-
depleted cells, we examined the effect of N-acetylcysteine (NAC), a
general antioxidant. As shown in Fig. 5A (lane 4 vs. 3, lane 6 vs. 5),
NAC suppressed the phosphorylation of ATM (Ser1981), Chk2 (Thr68)
and p53 (Ser15) at 1 and 3 h of recovery following azide-induced ATP
depletion. Surprisingly, γH2AX level was not suppressed, but further in-
duced by NAC (Fig. 5B). Immunoﬂuorescence staining detected ~35%
Fig. 4. Inhibition of DDR following azide treatment by Z-VAD and Bcl-2. (A) RPTC cellswere left untreated (control) or treatedwith 10mMsodiumazide for 3 h followed by recovery of 0, 1,
or 3 h in the presence or absence of 50 or 100 μMZ-VAD.Whole cell lysate was collected for immunoblot analysis of phosphorylated (Serine 1981) ATM, phosphorylated H2AX (γH2AX),
PARP, cleaved Caspase3, phosphorylated (threonine 68) Chk2, total Chk2, phosphorylated (Serine 15) p53, total p53, andβ-actin as a loading control. (B) Regular andBcl-2-overexpressing
RPTCs were left untreated (control) or treated with 10 mM sodium azide for 3 h followed by reperfusion of 0, 1, or 3 h. Whole cell lysate was collected for immunoblot analysis of phos-
phorylated (Serine 1981) ATM, phosphorylatedH2AX (γH2AX), phosphorylated (threonine 68) Chk2, total Chk2, phosphorylated (Serine 15) p53, total p53, and Cyclophilin B as a loading
control. (C) The percentage of apoptosis in RPTC and Bcl-2 cells after azide treatment and reperfusion was determined by counting the cells with typical apoptotic morphology.
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was increased to over 60% by NAC (Fig. 5C, D).
3.6. NAC increases apoptosis during recovery of ATP-depleted cells
The γH2AX increase by NAC during recovery of ATP-depleted RPTCs
in above Fig. 5 was intriguing. We noticed that NAC increased apoptosis
in this experiment (Fig. 6A). For quantiﬁcation, we counted the cells
with typical apoptotic morphology. As shown in Fig. 6B, 3 h of recovery
of azide-treated cells induced ~40% apoptosis, which was further in-
creased to ~60% by NAC. With this result, we considered the possibility
that the γH2AX induction by NAC is secondary to the higher level of ap-
optosis and the associated DNA damage. In linewith this possibility, theFig. 5.NAC suppresses ATM activation following azide treatment. RPTC cells were left untreated
or absence of 10 mMNAC. (A)Whole cell lysate was collected at the indicated recovery time fo
68) Chk2, total Chk2, phosphorylated (Serine 15) p53, total p53, andβ-actin as a loading control
of phosphorylated H2AX (γH2AX), and β-actin as a loading control. (C) The cells were ﬁxed at 2
more than 3 γH2AX nuclear foci were counted to determine the percentage of γH2AX foci poscaspase inhibitor Z-VAD diminished γH2AX expression in the presence
of NAC (Fig. 6C). NAC treatment also decreased cell survival (Fig. 6D),
3.7. Inhibition of ATM increases apoptosis and γH2AX following ATP
depletion and decreases cell survival
ATM is an early sensor in DDR. Depending on the cellular context,
ATMmay activate the signaling pathway of cell death or of DNA repair.
To determine the role of ATM activation during recovery of ATP-
depleted cells, we tested the effect of Ku55933, a speciﬁc ATM inhibitor.
Ku55933 suppressed ATMphosphorylation during 1 and 3 h of recovery
periods (Fig. 7C: lane 4 vs. 3, lane 6 vs. 5). To some extent, Ku55933 also
suppressed Chk2 and p53 phosphorylation (Fig. 7C). Notably, Ku55933(control) or treatedwith 10mM sodium azide for 3 h followed by recovery in the presence
r immunoblot analysis of phosphorylated (Serine 1981) ATM, phosphorylated (threonine
. (B)Whole cell lysatewas collected at the indicated recovery time for immunoblot analysis
h of recovery and subjected to immunoﬂuorescence staining of γH2AX. (D) The cells with
itive cells. *, P b 0.05 vs. control; #, p b 0.05 vs. Rep2h.
Fig. 6.NAC increases apoptosis, induces γH2AX, and decreases cell survival following azide treatment. RPTCswere left untreated (control) or treatedwith 10mM sodium azide for 3 h and
then followed by recovery in the presence or absence of 10 mMNAC. (A, B) At 3 h of recovery, the cells were stainedwith Hoechst 33342 to record cellular morphology by phase contrast
microscopy and nuclear morphology by ﬂuorescencemicroscopy (A). (B) The percentage of apoptosis in each condition was determined by counting the cells with typical apoptoticmor-
phology. (C) RTPCswere recovered for 0 or 1 h in the presence or absence of 10mMNAC, 100 μMZ-VAD, or 10mMNAC+100 μMZ-VAD.Whole cell lysate was collected for immunoblot
analysis of phosphorylated H2AX (γH2AX) and β-actin (loading control). (D) RPTCs were left untreated (control) or treated with 10 mM sodium azide for 3 h and then followed by
reperfusion of 3 h in the presence or absence of 10 mM NAC. After the treatment, the cells were recovered for 24 h in full culture medium to determine cell viability by MTT assay.
Quantitative data are expressed as mean ± SD (n = 3). *, P b 0.05 vs. control, #, p b 0.05 vs. azide group.
1093Z. Ma et al. / Biochimica et Biophysica Acta 1842 (2014) 1088–1096increased apoptosis from ~44% to ~66% (Fig. 7A, B). γH2AX expression
seemed to be increased by Ku55933 as well, so did γH2AX nuclear
foci formation (Fig. 7C–E). Finally, we analyzed the effect of Ku55933
on long-term cell survival. To this end, cell viability was analyzed by
MTT assay 24 h after ATP-depletion treatment. As Shown in Fig. 7F,
Ku55933 decreased cell survival in a dose-dependent manner
(Fig. 7F). Thus, the inhibition of ATM increased cell death and decreased
cell viability in this in vitro model, suggesting that ATM activation plays
a cytoprotective role for cell survival.
4. Discussion
Ischemia–reperfusion injury in organs and tissues leads to the devel-
opment of ischemic diseases, including myocardial infarction, stroke in
the brain and acute kidney injury. DNA damage and DDR-related
proteins were reported to play important roles during ischemia–
reperfusion injury in brain and heart [36–39]. However, the evidence
of DDR in renal ischemia–reperfusion injury is sketchy, though the accu-
mulation of 8-oxo-dG and apoptosis-associated DNA cleavage in renal
tubular cells is known to occur in kidney tissues following ischemia–
reperfusion [8–10]. In the present study, we have demonstrated the
evidence of DDR in kidney tissues following ischemic–reperfusion
injury in mice. Using the in vitro model of ‘chemical hypoxia’, we have
further suggested the involvement of ATP depletion, oxidative stress,
and apoptosis in the induction of DDR in renal tubular cells.
In general, the DDR shown in the in vitro model recapitulates the
main features of that of in vivo renal ischemia/reperfusion. Especially,
the phosphorylation of ATM, H2AX, Chk2 and p53 that are indicative
of the activation of these proteins was all increased in both the in vitro
and in vivo models. The expression of total proteins showed some dif-
ferences between these twomodels. For example, total ATMwasmark-
edly induced during renal IRI, but it did not change signiﬁcantly duringrecovery or ‘reperfusion’ of ATP-depleted cells (Figs. 1, 2). In addition,
total p53 accumulation was more evident in reperfused tissues than
ATP-depleted cells, whereas p53 phosphorylation at ser-15 was more
evident in the cells. These differences may result from the differences
between the in vitro and in vivo models. Obviously, kidney tissues are
much more complex as there are multiple cell types and during renal
IRI, inﬂammatory cells also inﬁltrate into renal interstitium [1,2,40].
p53 plays a role in ischemic kidney injury [11,41,42]. P53 and Chk2
regulate the G2/M transition in response to stress and DNA damage as
well [43,44]. Enhanced expression of p-ATM and p-Chk2 was reported
in the post-ischemic kidneys and G2/M arrest induced by enhanced ex-
pression of p-Chk2 is associated with proﬁbrotic cytokines production
and kidney ﬁbrosis progression after ischemia-reperfusion injury in kid-
ney [45,46]. In this study, up regulated P53 and p-Chk2 both in
ischemia-reperfused kidney cortex and ATP-depleted RPTC may partic-
ipate in cellular repair and recovery by inducing cell cycle arrest, a pos-
sibility that needs to be tested in future study.
The signaling pathway activated during DDR is dependent on the
type and extent of DNA damage. In our study, ATM showed an early
phosphorylation or activation during the recovery of ATP-depleted
cells, suggesting that ATM is a DNA damage sensor in this model. How-
ever, in the presence of NAC or Ku55933, while ATM activation was
inhibited,γH2AX increased. Since both NAC and Ku55933 increased ap-
optosis during ATP depletion/recovery, the observed γH2AX induction
is likely related to apoptosis-associated DNA damage. Under this
condition, other DNA damage sensors such as ATR and DNA-PK may
be activated to phosphorylateH2AX, a possibility that needs to be inves-
tigated in future studies.
In our study, the addition of glucose during azide treatment sup-
pressed DDR. Glucose is themajor substrate of glycolysis that promotes
ATP production in RPTCs, especially under conditions of mitochondrial
inhibition [47]. The suppressive effect of glucose on DDR in the
Fig. 7. Inhibition of ATM increases apoptosis andγH2AX and decreases cell survival following azide treatment. RPTCswere left untreated (control) or treatedwith 10mM sodiumazide for
3 h and then followed by recovery of 1, 2 or3 h in the presence or absence of 10 μM Ku55933. (A, B) The cells were stained with Hoechst 33342 to record cellular morphology by phase
contrast microscopy and nuclear morphology by ﬂuorescence microscopy (A). The percentage of apoptosis in each condition was determined by counting the cells with typical apoptotic
morphology (B). (C)Whole cell lysatewas collected for immunoblot analysis of phosphorylated (Serine 1981) ATM, total ATM, phosphorylated (threonine 68) Chk2, total Chk2, phosphor-
ylated (Serine15) p53, total p53, phosphorylatedH2AX(γH2AX), total H2AX andβ-actin (loading control). (D, E) RPTCs at 2 h of reperfusionwereﬁxed for immunoﬂuorescence ofγH2AX
and nuclear stainingwith DAPI. The representative images of γH2AX and DAPI stainingwere recorded (D) and the cells withmore than 3 γ-H2AX nuclear foci were counted to determine
the percentage of γH2AX positive cells (E). (F) After the treatment, the cells were recovered for 24 h in full culture medium to determine cell viability byMTT assay. Quantitative data are
expressed as mean ± SD (n = 3). *, P b 0.05 vs. control, #, p b 0.05 vs. azide group.
1094 Z. Ma et al. / Biochimica et Biophysica Acta 1842 (2014) 1088–1096‘chemical hypoxia’ model indicates that the DDR is a result of ATP-
depletion-triggered cell injury. This is not surprising because ATP deple-
tion is largely responsible for the initiation of cell injury processes in this
model, culminating inmitochondrial damage and ultimate cell death by
apoptosis [17,26]. In this regard, our results also support a role of apo-
ptosis in DDR in the ATP-depletion/recovery model. The work from us
and others has demonstrated that renal tubular cells undergo apoptosis
during ischemia–reperfusion in vivo and ATP-depletion in vitro via the
intrinsic pathway mediated by mitochondrial injury [24,47]. In this ap-
optotic pathway, the activation of Bax and Bak leads to mitochondrial
outer membrane permeabilization and the release of apoptotic factors
including cytochrome c, which further activates caspases for the devel-
opment of apoptosis. Bcl-2 antagonizes Bax and Bak to prevent mito-
chondrial permeabilization and inhibit apoptosis. In the present study,
DDR was suppressed by the pan-caspase inhibitor Z-VAD and Bcl-2,
supporting the involvement of apoptosis in the DDR. Apoptosis is
often associated with internucleosomal DNA cleavage, which occurs in
kidney tissues during renal ischemia–reperfusion [10]. Thus, the DDR
observed in the present study is partly attributable to apoptosis-
associated DNA damage.
Although both Z-VAD and Bcl-2 blocked apoptosis in our study, the
effect of Z-VAD on DDRwas less than that of Bcl-2 (Fig. 4). This observa-
tion suggests thepresence of othermechanisms ofDDR induction, in ad-
dition to apoptosis. The primary action of Bcl-2 is the protection of
mitochondria, resulting in inhibition of caspase activation and apopto-
sis. Based on this consideration, our results support an apoptosis-
independent role of mitochondrial damage in triggering DDR, although
the underlying mechanism is currently unclear. It is suggested that
there are two phases of DDR activation in the ATP-depletion/recovery
model. The initial phase of DDR activation is indicated by the ATMactivation, which is mainly due to mitochondrial injury, resulting in a
mild γH2AX induction. The inhibitory effect of NAC suggests that oxida-
tive stress may also contribute to the early activation of ATM, probably
as a result of mitochondrial injury. The ATM activation in this study
leads to the downstream phosphorylation of Chk2 and p53. Some
reports show that NAC protects against drug and oxidative stress-
induced apoptosis [48–53]. However, NAC has also been shown to
induce apoptosis in multiple types of cells by increasing the pro-
apoptotic Bax gene expression, or by inhibiting expression of anti-
apoptotic proteins Bcl-2, or via the ER stress response-signaling
pathway [29,54,55]. Our studies show that NAC treatment enhances ap-
optosis and decreased cell survival following ATP-depletion injury in
RPTC (Fig. 6). NAC may exert this effect partially by inhibiting ATM, a
surviving signaling pathway in this model, but further studies need to
delineate the ﬁnding. The second phase of DDR is apoptosis or caspase
activation related, and is mainly indicated by the massive induction of
γH2AX. As discussed above, apoptosis-associated DDR seems less de-
pendent on ATM, because Ku55933 completely blocked ATM activation
yet increase γH2AX induction and apoptosis. According to our results,
the initial phase of DDR mediated by ATM after mitochondrial injury
may be cytoprotective, while the second phase of DDR indicated by
massive γH2AX induction is mainly an indication of extensive DNA
damage in apoptosis. ATM is known to activate the mechanism of
DNA repair in DDR, which may account for the cytoprotective effect of
ATM in our study. In addition, ATM may be involved in the regulation
of antioxidant defense [56]. In support of this possibility, ATMmutation
or deﬁcientwere reported to affect cellular antioxidant status, including
decreased amounts of antioxidant molecules and glutathione biosyn-
thesis in A–T cells and increased concentrations of superoxide anions
in the cerebella in ATM−/−mice [57–59].
ROSMitochondrial  injury
ATM activation ATM-I
NAC
DNA damage response
γH2AX 
Cell survival
Z-VAD
Ischemia/Reperfusion
Caspase activation
Bcl-2
Apoptosis
Fig. 8. A schematic summary of DDR in cell death and survival following ischemia–
reperfusion.
1095Z. Ma et al. / Biochimica et Biophysica Acta 1842 (2014) 1088–1096In conclusion, this study has demonstrated the occurrence of DDR
during renal ischemia–reperfusion in vivo and ATP-depletion injury
in vitro. The DDR may consist of two phases (Fig. 8). The ﬁrst phase of
DDR ismediated byATMand depends onmitochondrial injury,whereas
the second phase is indicated by γH2AX induction and is consequent to
tubular cell apoptosis. ATM-mediated DDR may have a cytoprotective
role. Modulation of the DDRmay therefore offer a new strategy for kid-
ney protection during renal ischemia–reperfusion.References
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